USPTO serial 78094940
ENDPOINT RESEARCH LTD.
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Mar 4, 2003
- Examiner
- MEIER, SHARON A
- Law office
- SCANNING ON DEMAND
What this means
Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.
Need help with ENDPOINT RESEARCH LTD.?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Owner
Mississauga, Ontario, CA
Mississauga, Ontario, CA
Mississauga, Ontario, CA
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Gordon E. R. Troy
GORDON E R TROY GORDON E R TROY, PCP O BOX 368; 3333 LAKE RDCHARLOTTE, VT 05445UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 035 | Business services, namely providing computer databases regarding clinical trials for others by means of a global computer network; packaging services for the pharmaceutical industry, namely, packaging pharmaceuticals to the order and specification of others for use in clinical trials; computerized database management and data processing services in the fields of health care, pharmaceuticals, veterinary, pharmacogenomic, biotechnical, and medical products and devices; customized analysis of health care, pharmaceutical, veterinary, pharmacogenomic, biotechnical and medical products and devices data for others; business marketing research, business auditing and business consulting services in the fields of health care, pharmaceuticals, veterinary, pharmacogenomic, biotechnical, and medical products and devices provided by non-electronic means or by means of wide area networks or a global computer network; and distribution, tracking and management of clinical trial supplies and research materials used in such trials; and providing statistical information and analysis via computer for use with clinical trial data | SECTION 8 - CANCELLED | Aug 1, 1996 |
| 042 | Medical and scientific research, namely conducting clinical trials; collecting and providing information regarding clinical trials by means of a global computer network for purposes of improving clinical trial management; providing pharmaceutical outsourcing services in the field of clinical trials by means of a global computer network, namely, organizing and reporting data from clinical trials for pharmaceuticals and medical devices; bioanalytical immunoanalytical, and protein chemistry analytical services provided to pharmaceutical companies in connection with clinical studies of pharmaceuticals; providing contract research and development services in the field of pharmaceuticals and medical devices Computer services, namely, providing an on-line database in the field of pharmaceuticals; computer services, namely, providing on-line conferencing services in the field of pharmaceuticals; computer services, namely, providing on-line information, news and reports of new developments in the field of pharmaceuticals; providing information on non-clinical studies of pharmaceuticals and medical devices via the Internet; providing information in the fields of health care, pharmaceuticals, veterinary, pharmacogenomic, biotechnical, and medical products and devices by means of wide area networks or a global computer network; consulting services in the fields of health care, pharmaceuticals, veterinary, pharmacogenomic, biotechnical, and medical products and devices provided by non- electronic means or by means of wide area networks or a global computer network; clinical research services, namely, conducting programs to assist patients in pharmaceutical and medical device clinical trails in their transition from experimental to mass-approved products and treatments; Medical and scientific research, namely providing clinical trial analysis and studies, and data preparation for use by insurance companies and third party medical reimbursement organizations to determine treatment coverage; providing clinical trial data information via the world wide web | SECTION 8 - CANCELLED | Aug 1, 1996 |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Endpoint Research Ltd
- Other trademarks owned by Endpoint Research Ltd
- Other trademarks owned by Endpoint Research Ltd
- Other trademarks in Class 035
- Other trademarks in Class 042
- Similar marks named ENDPOINT RESEARCH LTD.
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Oct 10, 2009 | C8.. | CANCELLED SEC. 8 (6-YR) | — |
| Mar 3, 2008 | CFIT | CASE FILE IN TICRS | — |
| Mar 4, 2003 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Dec 10, 2002 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Nov 20, 2002 | NPUB | NOTICE OF PUBLICATION | — |
| Sep 14, 2002 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Aug 29, 2002 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Aug 8, 2002 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Apr 10, 2002 | CNRT | NON-FINAL ACTION MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 22, 2002 | DOCK | ASSIGNED TO EXAMINER | — |